Indian equity markets have a limited upside potential in the near-term as they negotiate the ensuing cyclical slowdown, wrote analysts at Nomura in a recent coauthored report led by Saion......
The correction seen in the stock markets thus far is insufficient and there are significant downside risks, given the way macroeconomic data is shaping up, a Nomura equity strategist said on......
Thus far in FY21, BSE, NSE have rallied 70 per cent and 71 per cent, respectively. Foreign portfolio investors (FPIs) continue to bet big on ‘India story’ with their net investment in......
Liquidity issues post the crisis at DHFL, progress of monsoon, rupee trajectory at the domestic level and oil prices are some factors that will keep markets choppy, analysts say. With less than a......
The company has launched only 3 new products during 2015 when compared to 14 launches in 2014 Dr Reddy’s Laboratories (DRL) is likely to leverage its relationship with existing and new......